A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

British Journal of Clinical Pharmacology

Volumn 42, Issue 6, 1996, Pages 757-763

  Price, John S ^a   Waller, Patrick C ^a   Wood, Susan M ^a   Mackay, Angus V P ^b  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

fluoxetine; fluvoxamine; paroxetine; sertraline; spontaneous adverse reaction reports; withdrawal reactions

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY NEUROSIS; ARTICLE; DRUG SAFETY; DRUG WITHDRAWAL; HEART PALPITATION; HUMAN; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; TREMOR; VERTIGO; WITHDRAWAL SYNDROME;

EID: 0029904001     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.00498.x     Document Type: Article

References (18)

1. Aguglia E, Cassacchia M, Cassana GB, et al. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993; 8: 197-202.
2. De Wilde J, Spiers R, Mertens C, Bartholeme F, Schotte G, Leyman S. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiat Scand 1993; 87: 141-145.
3. Van Moffaert M, Bartholeme F, Cosyns P, De Nayer AR, Mertens C. A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Human Psychopharmacol 1995; 10: 393-405.
4. Price J, Waller P, Wood S, Mackay A. Safety of fluoxetine: comparison with fluvoxamine. Pharmacoepidemiology and Drug Safety 1992; 1: 111-117.
5. Wood SM, Coulson R. Adverse drug reaction on-line information tracking (ADROIT). Pharmaceutical Med 1993; 7: 203-13.
6. Rawlins MD. Spontaneous reporting of adverse drug reactions I: The data. Br J Clin Pharmacol 1988; 26: 1-5.
7. Committee On Safety of Medicines and Medicines Control Agency. Dystonia and withdrawal symptoms with paroxetine (Seroxat). Current Problems in Pharmacovigilance 1993; 19: 1.
8. Rawlins MD. Spontaneous reporting of adverse drug reactions. Quart J Med 1986; 59: 531-534.
9. Mitchell PB. Selective serotonin reuptake inhibitors: adverse effects, toxicity and interactions. Adverse Drug Reactions and Toxicology Reviews 1994; 13: 121-144.
10. De Jonghe F, Swinkels JA. The safety of antidepressants. Drugs, 1992; 43 (Suppl. 2): 40-47.
11. Inman W, Kubota K, Pearce G, Wilton L. PEM Report Number 6 Paroxetine. Pharmacoepidemiology and Drug Safety 1993; 2: 393-422.
12. Herman JB, Brotman AW, Polack MH, et al. Fluoxetine-induced sexual dysfunction. J Clin Psychiat 1990; 51: 25-27.
13. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiat 1993; 54: 209-212.
14. Borg S, Brodin K. Antidepressants. In Meyler's Side Effects of Drugs, 12th edition, ed. Dukes MNG, Elsevier, 1992: 30-78.
15. Louie AK, Lannon RA, Ajari LJ. Withdrawal reaction after sertraline discontinuation. Am J Psychiat 1994; 151: 450-451.
16. Mallya G, White K, Gunderson C. Is there a serotonergic withdrawal syndrome? Biol Psychiat 1993; 33: 851-852.
17. Szabadi E. Fluvoxamine withdrawal syndrome. Br J Psychiat 1992; 160: 283-284.
18. Koopowitz LF, Berk M. Paroxetine induced withdrawal effects. Human Psychopharmacol 1995; 10: 147-148.